Perfil dos pacientes atendidos no ambulatório de demência de um hospital universitário by TASCONE, Lyssandra dos Santos et al.
Arq Neuropsiquiatr 2008;66(3-B):631-635
 631
CHARACTERISTICS OF PATIENTS ASSISTED 
AT AN AMBULATORY OF DEMENTIA 
FROM A UNIVERSITY HOSPITAL
Lyssandra dos Santos Tascone1, Rita de Cássia G. Marques1,  
Elaine Cristina Pereira1, Cássio M.C. Bottino2 
Abstract – Objective: To present socio-demographic characteristics, mean scores of tests and scales applied to 
patients with dementia and discuss the relationship between test scores, clinical diagnoses and the severity 
of dementia.  Method: Patients (n=113) were diagnosed according to the DSM-IV criteria, and the diagnostic 
work-up included physical and neurological examination, auxiliary exams, cognitive and functional tests, and 
the evaluation of neuropsychiatric symptoms.  Results: Mean age was 74.0 years. Alzheimer’s disease (AD) 
was diagnosed in 62.8% of the patients, AD and vascular dementia in 8.8%, other dementias in 14.2%, and mild 
cognitive impairment in 2.7%. At least one neuropsychiatric symptom was diagnosed in 96.9% of the sample. 
There were significant differences on cognitive and functional performance between the groups classified 
according to dementia severity.  Conclusion: Neuropsychiatric symptoms were quite common in patients with 
dementia, being more frequent as severity increased, and those symptoms were associated with functional 
impairment in the patients. 
KEY WORDS: dementia, Alzheimer’s disease, vascular dementia, neuropsychiatric symptoms, activities of daily 
living.
Perfil dos pacientes atendidos no ambulatório de demência de um hospital universitário
Resumo – Objetivo: Apresentar características demográficas, escores médios de testes e escalas aplicadas 
aos pacientes com demência e discutir a relação dos escores dos testes com os diagnósticos clínicos e a 
gravidade da demência.  Método: Pacientes (n=113) foram diagnosticados segundo os critérios para demência 
do DSM-IV, avaliados com história clínica, exame físico, exames complementares e aplicação de testes 
cognitivos, funcionais e neuropsiquiátricos.  Resultados: A idade média foi 74,0 anos. A doença de Alzheimer 
(DA) foi diagnosticada em 62,8% dos casos, DA e demência vascular em 8,8%, outras demências em 14,2%, e 
comprometimento cognitivo leve em 2,7%, Ao menos um sintoma neuropsiquiátrico foi diagnosticado em 
96,9% da amostra. Houve diferenças significativas nos escores dos testes cognitivos e escalas funcionais entre 
os grupos classificados segundo a gravidade de demência.  Conclusão: Sintomas neuropsiquiátricos são muito 
comuns, mais freqüentes em casos graves, e estes sintomas estão associados ao comprometimento funcional 
nos pacientes com demência. 
PALAVRAS-CHAVE: demência, doença de Alzheimer, demência vascular, sintomas neuropsiquiátricos, atividades 
de vida diária.
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The elderly population has increased all over the 
world, especially in developing countries. The prediction 
is that, by 2025, Brazil will have become the sixth coun-
try in the world, taking into account the number of el-
derly1,2, and that they will represent 12.5% of the world’s 
population3. With the increase of the elderly population, 
typical diseases in this age group become more frequent, 
among which are degenerative and vascular dementia, 
with all their socio-economic implications2. In this age 
group, memory problems affect 50% of the individuals 
and 5 to 10% of them are dementia patients’3.
The assistance to patients with cognitive disorder is 
often carried through at specialized clinics in universi-
ty centers. This assistance enables the adequate etiolog-
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ic identification, which does not often occur at centers of 
primary care, favoring an early treatment of cases of de-
generative or reversible causes and the improvement of 
knowledge through research.
The aim of this study is to present demographic charac-
teristics and the scores of tests applied to patients assist-
ed at the Ambulatory of Dementia of PROTER, and to dis-
cuss the relationship between the results of the tests with 
the etiologic diagnoses and the severity of the dementia.
METHOD
The activities at the Ambulatory of Dementia of PROTER, at 
the Institute of Psychiatry of Old Age Research Group (PROTER), 
Institute of Psychiatry, Medical School, University of São Pau-
lo, were initiated in February 2003. Records of patients assessed 
from February/2003 to June/2005 were analyzed. The patients 
who searched for the service spontaneously, complaining of for-
getfulness, were sent from other services or took part in an Epi-
demiologic Study of Prevalence of Dementia carried out in São 
Paulo. The assessment consists of clinical data of history, neu-
rological and physical exam, auxiliary tests and exams (labora-
tory and neuroimaging), in which the diagnosis of dementia and 
other mental disorders were made according to DSM-IV4 crite-
ria. The diagnosis of mild cognitive impairment (MCI) was made 
according to the criteria suggested by Petersen et al.5. The Bra-
zilian versions of the following tests and scales were applied: 
Cambridge Cognitive Examination (CAMCOG) from the Cam-
bridge Examination of Mental Disorders in the Elderly (CAM-
DEX)6,7, Mini-Mental State Examination (MMSE)8,9; to the infor-
mants, Neuropsychiatry Inventory (NPI)10,11, and Bayer Activities 
of Daily Living Scale (B-ADL)12,. Patients were classified accord-
ing to dementia severity, in 3 groups, based on the Clinical De-
mentia Rating Scale (CDR)13,14.
For two years and six months, 180 patients with memory com-
plaints were assisted and studied. Out of the 180 patients, 113 had 
complete assessment with etiologic diagnosis, which will be pre-
sented next. The others remained under investigation until the mo-
ment of data analysis and were directed to other services or dis-
missed, as they did not present significant cognitive deficits which 
would justify their permanence in this specialized ambulatory.
For the data analysis, the SPSS 14.0 Windows program was 
used. Descriptive analysis (minimum, maximum, standard devi-
ation), comparison of category frequencies with Qui-square and 
comparison of score averages of tests with Variance Analysis 
(ANOVA), or Kruskal-Walis non-parametric test, when appropri-
ate, with comparison pos-hoc, corrected by Bonferroni’s method 
were made. A linear regression was made, investigating the age 
effect, cognitive deficits and the presence of neuropsychiatric 
symptoms over the patients’ functional capacity.
All participants in this study and their informants signed a 
voluntary and consent term of awareness, which was approved 
by the Ethics Commission for Analysis of Research Projects of 
Medical School, University of São Paulo.
RESULTS
Demographic data of the sample (n=113) are present-
ed in Table 1. The average age of the sample was 74.0 (ex-
tremes: 51–92; sd=7.6) and the score of MEEM was 16.9 
(range: 2–30; sd=6.6).
The distribution of the frequency of diagnosis at the 
ambulatory is presented in Table 2. The diagnosis of oth-
er dementias comprises patients with vascular demen-
tia (VD), Lewy body dementia, fronto-temporal demen-
tia, Parkinson disease dementia, primary progressive apha-
sia, and dementia caused by other diseases (HIV, hypothy-
roidism and brain tumor+neurosurgery). The other diag-
nosis group comprises patients with vitamin B12 deficien-
cy, disorder of alcohol dependence and delirious disorder 
without dementia.
Major depression constituted a comorbity in 25 pa-
tients (22.1%) of this sample, 12 (48%) of whom were diag-
nosed with Alzheimer disease dementia (AD).
Analyzing the distribution of demographic data (gen-
der, marital status and years of education) there was no 
statistically significant difference between the six diag-
nostic groups described in Table 2.
Dementia cases (n=97), 94 (96.9%), patients presented 
at least neuropsychiatric symptoms assessed by neuro-
Table 1. Demographic data.
Variable Frequency Percentage (%)
Gender
  Male
   Female
49
64
43.4
56.6
Marital status
   Married
   Divorced
   Single
   Widowed
58
11
5
39
51.3
9.2
4.4
34.5
Education
   Illiterate
   1–4 years
   5–8 years
   ≥9 years
15
61
16
21
13.3
54.0
14.2
18.6
Table 2. Frequency of diagnosis found at the ambulatory.
Diagnostic Frequency Percentage (%)
Alzheimer’s disease (AD) 71 62.8
AD + Vascular dementia 10 8.8
Other dementias 16 14.2
Depression 9 8.0
Other diagnosis 4 3.5
Mild cognitive impairment (MCI) 3 2.7
Total 113 100
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psychiatric symptoms (NPI). The 3 (3.1%) cases of demen-
tia without neuropsychiatric symptoms presented diag-
nosis of Alzheimer disease.
A comparison between the average of the tests scores 
applied (MEEM, CAMCOG, NPI, B-ADL) with patients 
with dementia (n=97), was made, divided in 3 groups (AD, 
AD=VD and other dementias). The analysis of these data 
did not evidence a statistically significant difference in 
the tests scores. Only in relation to the neuropsychiat-
ric symptoms, a trend was observed (p=0.09) in patients 
with AD, who present lower scores than the AD+DV and 
other dementias patients. The scores average in the NPI 
scale, according to the diagnosis, was 28 to the patients 
with AD; 33 to those classified in the AD+DV group; and 
40.6 to patients in the other dementias group.
In the comparison between the severity of the dis-
ease (assessed by CDR) with the averages of scores applied 
(MEEM, CAMCOG, NPI, B-ADL) in patients with dementia, 
statistically significant differences (p<0.01) of groups clas-
sified according to CDR with MEEM, CAMCOG and NPI 
were observed. More serious cases (higher CDR score) pre-
sented lower scores in the MEEM and CAMCOG and high-
er in NPI and B-ADL (Table 3).
Finally, a linear regression was made, assessing the ef-
fect of cognition (MEEM), and the neuropsychiatric symp-
toms, over the functional impairment (B-ADL). The re-
sults show that, controlling the age effect, the function-
al impairment was significantly associated with cognition 
(MMSE) and with the neuropsychiatric symptoms, making 
it possible, with these variables, to explain 54.8% of the 
data variability (R2=0.548) (Table 4).
DISCUSSION
It was observed female predominance in the patients 
assisted at PROTER’s ambulatory of dementia (56.6%) and 
among patients with diagnosis of AD (62.8%), similar data 
to the ones found in medical literature. For instance, a 
Cuban study that investigated the prevalence of demen-
tia syndrome, in which 281 patients were assessed, there 
was female predominance (63.4% of samples)3. Revising 
the epidemiologic studies of dementia prevalence from 
1994 to 2000, it was observed higher prevalence of female 
dementia in several geographic areas researched1. With re-
gards to other demographic factors, 51.3% of the patients 
assisted were married, 34% widowed, and the majority 
of the samples (54%) had from 1 to 4 years of education. 
Almeida15, studying the prevalence of psychiatric symp-
toms in patients from a university ambulatory service, 
described a similar sample, in which 60% were women, 
49.3% married, but with fewer years of education, as 37.3% 
reported they had never been to school. Vale et al.16 has 
also found similar results in which 57.3% were married and 
27.6% widowed with fewer years of education (on average 
3 years of education) in patients from an ambulatory of a 
tertiary hospital.
AD was the most frequent diagnosis in the sample 
studied. The prevalence found was 62.8% and AD associ-
ated to DV 8.8%. Martínez3 has found 53.7% prevalence of 
patients who presented AD of late onset, 26.8% vascu-
lar dementia and 19.5% Alzheimer disease + vascular de-
mentia. Our findings are also similar to those described 
in other reports of other Brazilian services. Takada et al.17 
described that AD was the most frequent diagnosis (164 
cases; 59.6%) at the neurology clinic from HC FMUSP. Silva 
et al.2, at a neurology ambulatory of tertiary hospital, evi-
denced a sample with vascular dementia prevalence of 
24.9% and AD of 23.7%, with predominance of mild and 
moderate cases (83.5% of cases). Reviewing the prevalence 
of dementia in community studies, Lopes and Bottino1 ob-
Table 3. Distribution of tests scores and scales according to disease severity.
CDR 1
n=35
CDR 2
n=47
CDR 3
n=15
Statistic test 
and p value
Mean (sd) Mean (sd) Mean (sd)
MEEM 20.86 (3.51)a,b 14.43 (3.81)c 6.93 (2.96) F=83.94; p<0.001
CAMCOG 67.09 (11.15)a,b 49.94 (13.94)c 18.17 (12.81) F=66.54; p<0.001
NPI 20.17 (19.17)a,b 33.70 (19.78) 45.40 (18.56) F=10.03; p<0.001
B-ADL 4.74 (2.13)a,b 7.89 (1.30)c 9.42 (0.46) KW=55.52; p<0.001
sd, standard deviation; F, ANOVA test value; KW, Kruskal-Walis test value; aCDR 1 vs CDR 2 – p<0.01; bCDR 1 vs. 
CDR 3 – p<0.01; cCDR 2 vs. CDR 3 – p<0.01 
Table 4. Age, cognition and influence of neuropsychiatric 
symptoms on functional impairment.
Model  Standardized 
coefficient 
Beta
t p value
1 (constant)
  Age 
  MEEM
  NPI
0.106
–0.473
0.468
3.128
1.509
–6.551
6.480
0.002
0.135
<0.001
<0.001
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served that AD was more prevalent than vascular demen-
tia in all geographic regions researched. The data found 
in our ambulatories, therefore, are in accordance with the 
literature, although it is a study of prevalence with con-
venience sample, which is not necessarily representative 
of the elderly residing in the community. 
Depression constituted a comorbidity in 22.1% of pa-
tients in this sample. In similar studies mentioned before, 
about the profile of patients assisted at university ambu-
latory service, 69.3% of patients with dementia reported 
the presence of sadness and/or loss of interest for things 
in SRQ-20 (Self Reporting Questionnaire)15. Probably, this 
higher prevalence occurred because depressive symptom-
atology was described, and not the diagnosis of depres-
sive disorder as in the present study. In any case, this find-
ing indicates the importance of assessment of psychiatric 
morbidity in patients with dementia, which has an impact 
on the carer and the patient’s suffering. Vale et al.16 ob-
served that more than half of his patients in the ambula-
tory of a tertiary hospital had other disorders associated 
with the demential syndrome, in which the most frequent 
disorders were alcoholism and depression. Depression, to-
gether with sleeping disorders, apathy and irritability were 
the most common symptoms in individuals with cognitive 
impairment non-dementia (CIND), and without cognitive 
deficit in the study of Peters et al.18. In a study carried 
out in our environment, which will be described in more 
detail afterwards, more details following described, anxi-
ety and sleeping alteration, followed by depression were 
the most common symptoms in CIND19 patients. These 
individuals with cognitive deficits must be observed with 
attention, due to the risk of developing dementia in the 
future and its potential therapeutic importance, which 
must be clarified.
The neuropsychiatric symptoms are commonly found 
in elderly patients with dementia and AD. These include 
agitation, depression, delirium, hallucination, physical and 
verbal aggression, perambulation, absence of sexual inhi-
bition, anxiety, irritability, euphoria, eating and sleeping 
disorders19. Among the most common symptoms, agita-
tion, depression, anxiety, irritability, apathy and abnormal 
motor behavior can be mentioned18. These neuropsychi-
atric symptoms are very common and serious when the 
disease is well established, but can also be present months 
or years before the diagnosis and precede the beginning 
of cognitive deficits in patients with AD18. NPI, together 
with “Behavioral Pathology in Alzheimer’s Disease Rat-
ing Scale” (BEHAVE-AD) and the “Manchester and Oxford 
University Scale for the Psycopathological Assessement 
of Demential”, has been used with the purpose of inves-
tigating the presence of psychiatric morbidity in patients 
with dementia17. The occurrence of at least one psychiat-
ric symptom was observed in almost all patients of our 
sample (97%), probably because it was an ambulatory 
specialized in dementia, of a university hospital. Tatsch 
et al.19 found, at least, one neuropsychiatric symptom in 
78.3% of patients with Alzheimer disease, in 33% of the 
patients with CIND, and in 15.4% of the healthy ones, in a 
study of prevalence of neuropsychiatric symptoms in the 
elderly from the community. Apathy (53.3%), depression 
(38.3), sleeping disorder (38.3%) and anxiety (25%) were 
the most frequent symptoms in the samples of patients 
with AD from that study19. These results partially repli-
cate the findings in other populational studies, that found 
apathy and depression the two most prevailing symptoms 
in patients with AD20,21. In our sample, the frequency of 
neuropsychiatric symptoms has increased according to 
the increase of the severity of the disease. Besides, they 
were more common in dementia causes other than AD. 
The relation between the prevalence of neuropsychiatric 
symptoms and the severity of dementia varied widely in 
the studies previously mentioned. For instance, without 
significant difference though, Tatsch et al.19 found 7.7%, 
16% and 23.4% of agitation/aggressiveness prevalence and 
15.4%, 28% and 47% of abnormal motor behavior in pa-
tients grouped into dementia severity, according to the 
scale CDR in 0.5, 1 and 2–3. The same happened to the 
assessment of functional capacity, which diminished with 
the severity of the disease, together with the increase of 
cognitive impairment. Apart from the relation with the 
cognitive impairment, it was observed that the functional 
capacity also depends on the incidence of neuropsychi-
atric symptoms, reinforcing their impact on the patient’s 
treatment and on the carer’s stress. Such relation can also 
be found in cases of cognitive impairment non-dementia, 
in which the degree of cognitive and functional deficit 
was higher in individuals with CIND and neuropsychiat-
ric symptoms18. Peters et al.18 found these associations, in 
which patients with CIND and neuropsychiatric symptoms 
were significantly worse than the ones without neuropsy-
chiatric symptoms, in functional measures, but there was 
no difference with regards to demographic, cognitive and 
neuropsychiatric variables.
Systematic assessment of patients with cognitive def-
icits, quantifying not only the cognitive and functional 
deficits, but also the neuropsychiatric symptoms, using 
the protocol presented in this study, can help early iden-
tification of these symptoms, making it advantageous to 
examine them also in individuals with risk of dementia18. 
The early identification of these symptoms is important, 
as they are associated with worse prognosis, increase of 
caring costs, increase in caregiver’s overload and early 
institutionalization of the elderly18,19, and also with the 
functional impairment, as it was observed in the present 
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study. An early diagnosis can enable the implementation 
of pharmacological and non-pharmacological therapeu-
tic intervention, which can have a positive impact on the 
patients and their relatives quality of life.
REFERENCES
	 1.	 Lopes	MA,	Bottino	CMC.	Prevalência	de	demência	em	diversas	regiões	
do	mundo:	análise	dos	estudos	epidemiológicos	de	1994	a	2000.	Ar��	
Neuropsi��uiatr	2002;60:61-69.
	 2.	 Silva	DW,	Damasceno	BP.	Demência	na	população	de	pacientes	do	Hos-
pital	das	Clínicas	da	UNICAMP.	Ar��	Neuropsi��uiatr	2002;60:966-999.
	 3.	 Martínez	VP.	Prevalencia	del	síndrome	demencial	en	la	población	
mayor	de	60	años.	Rev	Cubana	Med �en Integr 2004;20.	 	 	
	 4.	 American	Psychiatry	Association.	Diagnostic	and	statistical	manual	of	
mental	disorders,	4th	ed.	Washington,DC:	American	Psychiatric	Asso-
ciation,1994.
	 5.	 Petersen	RC,	Smith	�E,	Warring	SC,	Ivnik	RJ,	Tangalos	E�,	Kokmen	
E.	Mild	cognitive	impairment:	clinical	characterization	and	outcome.	
Arch	Neurol	1999;56:303-308.	
	 6.	 Bottino	CMC,	Almeida	OP,	Tamai	S,	Forlenza	OV,	Scalco	MZ,	Carva-
lho	IAM.	Entrevista	estruturada	para	diagnóstico	de	transtornos	men-
tais	em	idosos-CAMDEX_The	Cambridge	examination	for	mental	di-
sorders	of	the	elderly.	Versão	brasileira	(traduzida	e	adaptada	com	au-
torização	dos	editores,	Cambridge	University	Press),	São	Paulo,	1999.	
	 7.	 Bottino	CMC,	Stoppe	A	Jr,	Scalco	AZ,	Ferreira	RCR,	Hototian	R,	Scalco	
MZ. Validade e confiabilidade da versão brasileira do CAMDEX. Arq 
Neuropsi��uiatr	2001;59:20.
	 8.	 Folstein	MF,	Folstein	SE,	McHugh	PR.	The mini �mental state: a prac-	 	 	 	 	
tical	method	for	grading	the	cognitive	state	patients	for	the	clinician.	J	
Psychiatr	Res	1975;12:189-198.	
	 9.	 Brucki	SM,	Nitrini	R,	Caramelli	P,	Bertolucci	PH,	Okamoto	IH.	Sugges-
tions	for	utilization	of	the	mini-mental	state	examination	in	Brazil.	Ar��	
Neuropsi��uiatr	2003;61:777-781.	
10.	 Cummings	JL,	Mega	M,	�ary	K,	Rosenberg-Thompson	S,	Carusi	DA,	
�ornbein	J.	The	neuropsychiatric	inventory-comprehensive	assessment	
of	psychopathology	in	dementia.	Neurology	1994;44:2308-2314.	
11.	 Camozzato	AL,	Kochhann	R,	Simeoni	C,	et	al.	Reability of the Brazil-	 	 	
ian	portuguese	version	of	the	neuropsychiatric	inventury	(NPI)	for	pa-
cients	with	Alzheimer’s	disease	and	their	caregivers.	Int	Psychogeriatr	
2008;20:383-393.	
12.	 Fol��uitto	JC,	Bustamante	SE,	Barros	SB,	et	al.	The Bayer: activities of	 	 	 	
daily	living	scale	(B-ADL)	in	the	differentiation	between	mild	to	mod-
erate	dementia	and	normal	aging.	Rev	Bras	Psi��uiatr	2007;29:350-353.
13.	 Hughes	CP,	Danziger	WL,	Coben	LA,	Martin	RL.	A	new	clinical	scale	
for	the	staging	of	dementia.	Br	J	Psychiatry	1982;140:566-572;	update	
by	Morris	J.	The	CDR:	current	version	and	scoring	rules.	Neurology	
1993;43:2412-2413.
14.	 Chaves	ML,	Camozzato	AL,	�odinho	C,	et	al.	Validity	of	the	clinical	
dementia	rating	scale	for	the	detection	and	staging	of	dementia	in	Bra-
zilian	patients.	Alzheimer	Dis	Assoc	Disord	2007;21:210-217.	
15.	 Almeida	OP.	Sintomas	psi��uiátricos	entre	pacientes	com	demência	aten-
didos	em	um	serviço	ambulatorial.	Ar�� Neuropsi��uiatr 1999;57:937-943.	 	 	
16.	 Vale	FAC,	Miranda	SJC.	Clinical	and	demographic	features	of	patients	
with	dementia	attended	in	a	tertiary	outpatient	clinic.	Ar��	Neurop-
si��uiatr	2002;60:548-552.
17.	 Takada	LT,	Caramelli	P,	Radanovic	M,	et	al.	Prevalence	of	potentially	re-
versible	dementias	in	a	dementia	outpatient	clinic	of	a	tertiary	univer-
sity-affiliated hospital in Brazil. Arq Neuropsiquiatr 2003;61:925-929.
18.	 Peters	KR,	Rockwood	K,	Black	SE,	et	al.	Characterizing	neuropsychi-
atric	symptoms	in	subjects	referred	to	dementia	clinics.	Neurology	
2006;66:523-528.
19.	 Tatsch	MF,	Bottino	CMC,	Azevedo	D,	et	al.	Neuropsychiatric	symptoms	
in	Alzheimer	disease	and	cognitively	impaired,	nondemented	elderly	
from	a	community-based	sample	in	Brazil:	prevalence	and	relationship	
with	dementia	severity.	Am	J	�eriatric	Psychiatry	2006;14:438-445.
20.	 Lyketsos	C�,	Lopez	O,	Jones	B,	Fitzpatrick	AL,	Breitner	J,	DeKosky	S.	
Prevalence	of	neuropsychiatric	symptoms	in	dementia	and	mild	cogni-
tive	impairment:	results	from	the	Cardiovascular	Health	Study.	JAMA	
2002;288:1475�1483.
21.	 �eda	YE,	Smith	�E,	Knopman	DS.	�enesis	of	neuropsychiatric	symptoms	
in	mild	cognitive	impairment	(MCI).	Int	Psychogeriatr	2004;16:51-60.
